Calendar

pharmadog

Week of Apr 6, 2026

Apr 6, 2026approval128d agoIMATINIB MESYLATE — FDA approvalInhibikase Therapeutics, Inc.

Sponsor: EUGIA PHARMA. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Apr 6, 2026approval128d agoIMATINIB MESYLATE — FDA approvalInhibikase Therapeutics, Inc.

Sponsor: EUGIA PHARMA. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Apr 6, 2026approval128d agoKEYTRUDA (PEMBROLIZUMAB) — FDA approvalpembrolizumab

Sponsor: MERCK SHARP DOHME. Form: SOLUTION. Route: INTRAVENOUS

full page →pembrolizumab →fda approvals ↗

Apr 6, 2026approval128d agoDAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE (DAPAGLIFLOZIN) — FDA approvalDAPAGLIFLOZIN

Sponsor: MICRO LABS. Form: TABLET, EXTENDED RELEASE. Route: ORAL

full page →DAPAGLIFLOZIN →fda approvals ↗

Apr 6, 2026approval128d agoDAPAGLIFLOZIN — FDA approvalDAPAGLIFLOZIN

Sponsor: MICRO LABS. Form: TABLET. Route: ORAL

full page →DAPAGLIFLOZIN →fda approvals ↗

Apr 6, 2026approval128d agoDAPAGLIFLOZIN — FDA approvalDAPAGLIFLOZIN

Sponsor: AUROBINDO PHARMA. Form: TABLET. Route: ORAL

full page →DAPAGLIFLOZIN →fda approvals ↗

Apr 6, 2026approval128d agoDAPAGLIFLOZIN — FDA approvalDAPAGLIFLOZIN

Sponsor: BIOCON PHARMA. Form: TABLET. Route: ORAL

full page →DAPAGLIFLOZIN →fda approvals ↗

Apr 6, 2026approval128d agoDAPAGLIFLOZIN — FDA approvalDAPAGLIFLOZIN

Sponsor: MSN. Form: TABLET. Route: ORAL

full page →DAPAGLIFLOZIN →fda approvals ↗

Apr 6, 2026approval128d agoDAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE (DAPAGLIFLOZIN) — FDA approvalDAPAGLIFLOZIN

Sponsor: MSN. Form: TABLET, EXTENDED RELEASE. Route: ORAL

full page →DAPAGLIFLOZIN →fda approvals ↗

Apr 6, 2026approval128d agoDAPAGLIFLOZIN — FDA approvalDAPAGLIFLOZIN

Sponsor: AJANTA PHARMA LTD. Form: TABLET. Route: ORAL

full page →DAPAGLIFLOZIN →fda approvals ↗

Apr 6, 2026approval128d agoDAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE (DAPAGLIFLOZIN, METFORMIN HYDROCHLORIDE) — FDA approvalDAPAGLIFLOZIN

Sponsor: AUROBINDO PHARMA. Form: TABLET

full page →DAPAGLIFLOZIN →fda approvals ↗

Apr 6, 2026approval128d agoDAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE (DAPAGLIFLOZIN) — FDA approvalMicro Labs Ltd

Sponsor: SUN PHARM. Form: TABLET, EXTENDED RELEASE. Route: ORAL

full page →fda approvals ↗

Apr 6, 2026approval128d agoDAPAGLIFLOZIN — FDA approvalMSN Pharmaceuticals Inc

Sponsor: INVENTIA. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Apr 6, 2026approval128d agoDAPAGLIFLOZIN — FDA approvalDAPAGLIFLOZIN

Sponsor: MACLEODS PHARMS LTD. Form: TABLET. Route: ORAL

full page →DAPAGLIFLOZIN →fda approvals ↗

Apr 6, 2026approval128d agoDAPAGLIFLOZIN — FDA approvalMSN Pharmaceuticals Inc

Sponsor: AIZANT. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Apr 6, 2026approval128d agoKEYTRUDA QLEX (PEMBROLIZUMAB) — FDA approval(berahyaluronidase alfa + pembrolizumab)

Sponsor: MERCK SHARP DOHME. Form: INJECTABLE. Route: INJECTION

full page →(berahyaluronidase alfa + pembrolizumab) →fda approvals ↗

Apr 6, 2026approval128d agoDAPAGLIFLOZIN — FDA approvalDAPAGLIFLOZIN

Sponsor: LUPIN LTD. Form: TABLET. Route: ORAL

full page →DAPAGLIFLOZIN →fda approvals ↗

Apr 6, 2026approval128d agoDAPAGLIFLOZIN AND SAXAGLIPTIN HYDROCHLORIDE (DAPAGLIFLOZIN) — FDA approvalDAPAGLIFLOZIN

Sponsor: MSN. Form: TABLET. Route: ORAL

full page →DAPAGLIFLOZIN →fda approvals ↗

Apr 6, 2026approval128d agoDAPAGLIFLOZIN — FDA approvalDAPAGLIFLOZIN

Sponsor: CIPLA. Form: TABLET. Route: ORAL

full page →DAPAGLIFLOZIN →fda approvals ↗

Apr 6, 2026approval128d agoDAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE (DAPAGLIFLOZIN) — FDA approvalDAPAGLIFLOZIN

Sponsor: CIPLA LTD. Form: TABLET, EXTENDED RELEASE. Route: ORAL

full page →DAPAGLIFLOZIN →fda approvals ↗

Apr 6, 2026approval128d agoDAPAGLIFLOZIN AND SAXAGLIPTIN HYDROCHLORIDE (DAPAGLIFLOZIN) — FDA approvalDAPAGLIFLOZIN

Sponsor: TORRENT. Form: TABLET. Route: ORAL

full page →DAPAGLIFLOZIN →fda approvals ↗

Apr 6, 2026approval128d agoDAPAGLIFLOZIN — FDA approvalTeva Pharmaceuticals USA Inc

Sponsor: TEVA PHARMS USA. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Apr 6, 2026approval128d agoDAPAGLIFLOZIN — FDA approvalMSN Pharmaceuticals Inc

Sponsor: ALKEM LABS LTD. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Apr 6, 2026approval128d agoDAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE (DAPAGLIFLOZIN) — FDA approvalDAPAGLIFLOZIN

Sponsor: MACLEODS PHARMS LTD. Form: TABLET, EXTENDED RELEASE. Route: ORAL

full page →DAPAGLIFLOZIN →fda approvals ↗

Apr 6, 2026approval128d agoDAPAGLIFLOZIN — FDA approvalDAPAGLIFLOZIN

Sponsor: ALEMBIC. Form: TABLET. Route: ORAL

full page →DAPAGLIFLOZIN →fda approvals ↗

Apr 6, 2026approval128d agoDAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE (DAPAGLIFLOZIN) — FDA approvalMicro Labs Ltd

Sponsor: ALKEM LABS LTD. Form: TABLET, EXTENDED RELEASE. Route: ORAL

full page →fda approvals ↗

Apr 6, 2026approval128d agoDAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE (DAPAGLIFLOZIN) — FDA approvalDAPAGLIFLOZIN

Sponsor: LUPIN LTD. Form: TABLET, EXTENDED RELEASE. Route: ORAL

full page →DAPAGLIFLOZIN →fda approvals ↗

Apr 6, 2026approval128d agoDAPAGLIFLOZIN — FDA approvalZydus Therapeutics Inc

Sponsor: ZYDUS PHARMS. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Apr 6, 2026approval128d agoDAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE (DAPAGLIFLOZIN) — FDA approvalDAPAGLIFLOZIN

Sponsor: TEVA PHARMS USA INC. Form: TABLET, EXTENDED RELEASE. Route: ORAL

full page →DAPAGLIFLOZIN →fda approvals ↗

Apr 6, 2026approval128d agoDAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE (DAPAGLIFLOZIN) — FDA approvalDAPAGLIFLOZIN

Sponsor: CIPLA. Form: TABLET, EXTENDED RELEASE. Route: ORAL

full page →DAPAGLIFLOZIN →fda approvals ↗

Apr 6, 2026approval128d agoPAROXETINE HYDROCHLORIDE — FDA approvalPAROXETINE HYDROCHLORIDE

Sponsor: AUROBINDO PHARMA USA. Form: TABLET, EXTENDED RELEASE. Route: ORAL

full page →PAROXETINE HYDROCHLORIDE →fda approvals ↗

Apr 6, 2026approval128d agoPAROXETINE HYDROCHLORIDE — FDA approvalPAROXETINE HYDROCHLORIDE

Sponsor: AUROBINDO PHARMA USA. Form: TABLET, EXTENDED RELEASE. Route: ORAL

full page →PAROXETINE HYDROCHLORIDE →fda approvals ↗

Apr 6, 2026approval128d agoDAPAGLIFLOZIN — FDA approvalDAPAGLIFLOZIN

Sponsor: SANDOZ. Form: TABLET. Route: ORAL

full page →DAPAGLIFLOZIN →fda approvals ↗

Apr 6, 2026approval128d agoPAROXETINE HYDROCHLORIDE — FDA approvalPAROXETINE HYDROCHLORIDE

Sponsor: AUROBINDO PHARMA USA. Form: TABLET, EXTENDED RELEASE. Route: ORAL

full page →PAROXETINE HYDROCHLORIDE →fda approvals ↗

Apr 6, 2026approval128d agoPAROXETINE HYDROCHLORIDE — FDA approvalPAROXETINE HYDROCHLORIDE

Sponsor: AUROBINDO PHARMA USA. Form: TABLET, EXTENDED RELEASE. Route: ORAL

full page →PAROXETINE HYDROCHLORIDE →fda approvals ↗

Apr 6, 2026device 510k128d agoUzinmedicare Co., Ltd. — SPECTRA Wearable 2 (510k cleared)

Product code: HGX. Advisory committee: Obstetrics/Gynecology. Type: Traditional

full page →fda device 510k ↗

Apr 6, 2026device 510k128d agoVirility Medical , Ltd. — in2 Smart (in2S) (510k cleared)

Product code: QRC. Advisory committee: Gastroenterology, Urology. Type: Traditional

full page →fda device 510k ↗

Apr 6, 2026device 510k128d agoFujifilm Corporation — APERTO Lucent MRI System (510k cleared)Fujifilm Holdings Corp

Product code: LNH. Advisory committee: Radiology. Type: Traditional

full page →fda device 510k ↗

Apr 6, 2026device 510k128d agoEsaote, S.p.A. — 6450 Ultrasound System (MyLabE80); 6450 Ultrasound System (MyLabE85) (510k cleared)

Product code: IYN. Advisory committee: Radiology. Type: Traditional

full page →fda device 510k ↗

Apr 6, 2026device 510k128d agoRicoh 3D For Healthcare, LLC — Ricoh 3D for Healthcare Bolus (510k cleared)

Product code: IXI. Advisory committee: Radiology. Type: Traditional

full page →fda device 510k ↗

Apr 6, 2026device 510k128d agoZoll Respicardia, Inc. — VANES Delivery System (VDS) (510k cleared)

Product code: DYB. Advisory committee: Cardiovascular. Type: Traditional

full page →fda device 510k ↗

Apr 6, 2026device 510k128d agoShenzhen Mindray Bio-Medical Electronics Co., Ltd. — SV70 Ventilator (SV70) (510k cleared)

Product code: MNT. Advisory committee: Anesthesiology. Type: Traditional

full page →fda device 510k ↗

Apr 6, 2026device 510k128d agoSmith & Nephew, Inc. — AETOS Shoulder System - CONCELOC Glenoids (510k cleared)SMITH & NEPHEW PLC

Product code: KWS. Advisory committee: Orthopedic. Type: Traditional

full page →fda device 510k ↗

Apr 6, 2026device 510k128d agoZhuhai Pusen Medical Technology Co., Ltd. — ClearEVAC Ureteral Aspirating Access Sheath (PUS-100-1040,PUS-100-1050, PUS-100-1240,PUS-100-1250) (510k cleared)NewBay Medical Technology Co Ltd

Product code: FED. Advisory committee: Gastroenterology, Urology. Type: Traditional

full page →fda device 510k ↗

Apr 6, 2026device 510k128d agoAidite (Qinhuangdao) Technology Co., Ltd. — Light-curing Coloring Materials (ALCM) (510k cleared)

Product code: EBF. Advisory committee: Dental. Type: Traditional

full page →fda device 510k ↗

Apr 6, 2026device 510k128d agoHironic Co., Ltd. — SYNERJET PRO (SP-1002); InPhiuse (SP-1002); WOWJET (SP-1002) (510k cleared)

Product code: GEI. Advisory committee: General, Plastic Surgery. Type: Traditional

full page →fda device 510k ↗

Apr 6, 2026device 510k128d agoYAMAHACHI DENTAL MFG., Co. — GLOSSY COAT (15ML) (510k cleared)

Product code: EBD. Advisory committee: Dental. Type: Traditional

full page →fda device 510k ↗

Apr 6, 2026device 510k128d agoProsomnus Sleep Technologies — ProSomnus RPMO2 OSA Device (RPMO2 OSA) (510k cleared)

Product code: PLC. Advisory committee: Dental. Type: Traditional

full page →fda device 510k ↗

Apr 6, 2026grant128d agoUNIVERSITY OF PITTSBURGH AT PITTSBURGH — Interleukin 33 signaling beneficially regulates pathologic glia in multiple s...

AI grant. $157,788. PI: Sachin Gadani

full page →nih reporter ↗

Apr 6, 2026grant128d agoUNIVERSITY OF CALIFORNIA, SAN FRANCISCO — Development of a Humanized IL33 MouseUniversity of California San Francisco

AI grant. $174,824. PI: Erin D. Gordon

full page →nih reporter ↗

← prev

page 1 of 86

Week of Apr 6, 2026